Genus (GENSF) Market Cap : $1,360.5 Mil (As of Dec. 14, 2024)

View and export this data going back to . Start your Free Trial

What is Genus Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Genus's share price for the quarter that ended in Jun. 2024 was $21.13. Genus's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 65.7 Mil. Therefore, Genus's market cap for the quarter that ended in Jun. 2024 was $1,388.0 Mil.

Genus's quarterly market cap declined from Jun. 2023 ($2,303.1 Mil) to Dec. 2023 ($1,858.4 Mil) and declined from Dec. 2023 ($1,858.4 Mil) to Jun. 2024 ($1,388.0 Mil).

Genus's annual market cap increased from Jun. 2022 ($1,962.0 Mil) to Jun. 2023 ($2,303.1 Mil) but then declined from Jun. 2023 ($2,303.1 Mil) to Jun. 2024 ($1,388.0 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Genus's Enterprise Value for Today is $1,697.7 Mil.

Genus Market Cap Historical Data

The historical data trend for Genus's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus Market Cap Chart

Genus Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Market Cap

Get a 7-Day Free Trial

2,017.84

4,767.71

1,962.02

2,303.08

1,387.99

Genus Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Market Cap	Get a 7-Day Free Trial															1,962.02	2,249.81	2,303.08	1,858.36	1,387.99

Competitive Comparison of Genus's Market Cap

For the Biotechnology subindustry, Genus's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genus's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genus's Market Cap distribution charts can be found below:

* The bar in red indicates where Genus's Market Cap falls into.

Genus Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Genus's Market Cap for the fiscal year that ended in Jun. 2024 is calculated as

Market Cap (A: Jun. 2024 )	=	Share Price (A: Jun. 2024 )	*	Shares Outstanding (EOP) (A: Jun. 2024 )
	=	$21.13	*	65.6881
	=	$1,388.0

Genus's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )	=	Share Price (Q: Jun. 2024 )	*	Shares Outstanding (EOP) (Q: Jun. 2024 )
	=	$21.13	*	65.6881
	=	$1,388.0

Genus (OTCPK:GENSF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Genus Market Cap Related Terms

Thank you for viewing the detailed overview of Genus's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Genus Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (OTCPK:GENSF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

GNSl:UK GNS:UK GBE:Germany

Address

Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ

Website

https://www.genusplc.com

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.